Eupraxia Pharmaceuticals (EPRX) Other Non-Current Assets (2022 - 2026)
Eupraxia Pharmaceuticals (EPRX) recorded Other Assets of $53,702 in Q2 2026, down 31.0% from $77,842 a year earlier and down 13.0% from the prior quarter.
Powered by 
Analysis
Eupraxia Pharmaceuticals (EPRX) Other Non-Current Assets (2022 - 2026) Analysis & Trends
At the end of FY2025, Eupraxia Pharmaceuticals reported Other Assets of $64,332, down 20.3% from FY2024.
- Annual Other Assets has a three-year compound annual growth rate of 195.5% (FY2022 to FY2025).
- Across earlier years, Other Assets came in at $80,761 in FY2024, $6,904 in FY2023 (+177.0%) and $2,492 in FY2022.
- The Q2 2026 figure is the lowest quarterly Other Assets since Q1 2024.
- On a year-over-year basis, Other Assets has declined for five consecutive quarters, with an average decline of 51.7% over the last five quarters.
- Per Business Quant, the preceding three quarters came in at $61,754 (Q1 2026), $64,332 (Q4 2025) and $97,597 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 7.70 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 15.10 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 9.42 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 19.90 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 700.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 14.60 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.90 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 10.02 Bn |
| 10 | Eupraxia Pharmaceuticals | 304.87 Mn | -174.66 Mn | - | 50,594.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 50,594.00 |
| Jun 30, 2026 | 53,702.00 |
| Mar 31, 2026 | 61,754.00 |
| Dec 31, 2025 | 64,332.00 |
| Sep 30, 2025 | 97,597.00 |
| Jun 30, 2025 | 77,842.00 |
| Mar 31, 2025 | 80,230.00 |
| Dec 31, 2024 | 80,761.00 |
| Sep 30, 2024 | 1.12 Mn |
| Jun 30, 2024 | 1.05 Mn |
| Mar 31, 2024 | 5,571.00 |
| Dec 31, 2023 | 6,904.00 |
| Dec 31, 2022 | 2,492.00 |
API Access
Eupraxia Pharmaceuticals Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=EPRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "EPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=EPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();